Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.350
-0.020 (-1.46%)
Feb 21, 2025, 4:00 PM EST - Market closed
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of $8.33 million as of February 21, 2025. Its market cap has decreased by -40.51% in one year.
Market Cap
8.33M
Enterprise Value
5.07M
1-Year Change
-40.51%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since March 31, 2015, Aytu BioPharma's market cap has increased from $200.00K to $8.33M, an increase of 4,064.65%. That is a compound annual growth rate of 45.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 8.30M | -20.95% |
| Dec 31, 2024 | 10.50M | -33.54% |
| Dec 29, 2023 | 15.80M | 33.90% |
| Dec 30, 2022 | 11.80M | -68.95% |
| Dec 31, 2021 | 38.00M | -50.33% |
| Dec 31, 2020 | 76.50M | 278.71% |
| Dec 31, 2019 | 20.20M | 197.06% |
| Dec 31, 2018 | 6.80M | -30.61% |
| Dec 29, 2017 | 9.80M | 9,700.00% |
| Dec 30, 2016 | 100.00K | -66.67% |
| Dec 31, 2015 | 300.00K | 50.00% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |